NCT06535503 Clinical Characteristics and Outcomes Among STEMI Patients With Cardiogenic Shock at Abu Dhabi City
| NCT ID | NCT06535503 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Abu Dhabi Health Services Company |
| Condition | ST Elevation Myocardial Infarction |
| Study Type | OBSERVATIONAL |
| Enrollment | 400 participants |
| Start Date | 2024-07-01 |
| Primary Completion | 2025-01-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 400 participants in total. It began in 2024-07-01 with a primary completion date of 2025-01-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
A retrospective study on the clinical characteristics and treatment outcomes of patients admitted with ST-elevation Myocardial Infarction (STEMI) complicated with cardiogenic shock (CS) during admission or CS development during their hospital stay for two tertiary hospitals in Abu Dhabi, UAE, from 2020-2024.
Eligibility Criteria
Inclusion Criteria: * Age more than 18. * STEMI complicated by cardiogenic shock. * Were hospitalized or treated at SSMC or SKMC for STEMI complicated by cardiogenic shock. * Patient admitted between January 2019 to March 2024. Exclusion Criteria: * Age less than 18. * Shock patient not related to Myocardial infarction. * NSTEMI-related cardiogenic shock. * Patients who were not treated at SSMC or SKMC for the STEMI complicated by cardiogenic shock. * Patient not admitted between January 2019 to March 2024.
Contact & Investigator
Abdulmajeed BS Alzubaidi, MD
STUDY CHAIR
Abu Dhabi Health Services Co. -SEHA
Frequently Asked Questions
Who can join the NCT06535503 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying ST Elevation Myocardial Infarction. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06535503 currently recruiting?
Yes, NCT06535503 is actively recruiting participants. Contact the research team at alnaeem@seha.ae for enrollment information.
Where is the NCT06535503 trial being conducted?
This trial is being conducted at Abu Dhabi, United Arab Emirates, Abu Dhabi, United Arab Emirates.
Who is sponsoring the NCT06535503 clinical trial?
NCT06535503 is sponsored by Abu Dhabi Health Services Company. The principal investigator is Abdulmajeed BS Alzubaidi, MD at Abu Dhabi Health Services Co. -SEHA. The trial plans to enroll 400 participants.